Abstract Neuropeptides mediate stress-induced cutaneous inflammation such as atopic dermatitis. The effect of substance P on proliferation and cytokine mRNA expression of peripheral blood mononuclear cells in response to Dermatophagoides farinae (Der f) was studied in atopic dermatitis patients with positive RAST scores to Der f. Upon stimulation with Der f peripheral blood mononuclear cells from patients proliferated in a B7-dependent (CD80-and CD86-dependent) manner, while those from the patients with negative scores, nonatopic eczematous dermatitis patients or normal individuals, did not. Based on the reactivity of normal individuals, atopic dermatitis patients with a stimulation index greater than 1.8 were tentatively defined as high responders, who comprised two-thirds of the patients. Proliferation in high responders was associated with upregulation of IL-2 mRNA expression and induction of IL-5 mRNA expression. Substance P at 10 -10 to 10 -8 M promoted the Der f-induced proliferation when added at the start of culture and upregulated IL-10 mRNA expression while downregulating IL-5 mRNA expression. Our results suggest that substance P modifies immune responses of atopic T cells to Der f by promoting proliferation and altering cytokine profiles, and thus modulates the clinical manifestations of atopic dermatitis.
Introduction
House-dust mites (HDM) are the major source of environmental inhalation allergens. Freshly isolated T cells and T cell clones from patients with atopic dermatitis (AD) who are allergic to HDM recognize several peptides derived from Dermatophagoides pteronyssinus and Dermatophagoides farinae (Der f ) and proliferate to produce Th2 cell-type cytokines [14, 25, 27] . Preferential accumulation of allergen-specific Th2 cells strongly suggests their involvement in the establishment of skin lesions. In the study reported here we investigated the effect of substance P (SP) on responses of peripheral blood mononuclear cells (PBMC) from AD patients to HDM allergens. Proliferation of CD4 + T cells in response to Der f was associated with augmented or induced expression of mRNA for Th1 and Th2 cytokines. SP further enhanced proliferation and expresssion of IL-10 mRNA while suppressing IL-5 mRNA expression. These results suggest that cutaneous inflammation by HDM allergen-specific T cells is modulated by SP.
Materials and methods

Subjects
The study groups comprised: 25 patients with AD (aged: 16-39 years, mean age 26 years; 13 males and 12 females) and five patients with eczema and dermatitis (ED; 1 seborrhoeic dermatitis, 3 autosensitization dermatitis, and 1 asteatotic dermatitis; aged 38-53 years; mean age 42 years; 3 males and 2 females) as disease controls, and 13 normal healthy subjects (aged 26-39 years; mean age 30 years; 8 males and 5 females). Informed consent was obtained from each individual before inclusion in the study. The diagnosis of AD was based on the criteria of Hanifin and Rajka [13] , and all the patients had eczematous lesions on more than 10% of the body surface. Serum IgE levels in AD ranged from 530 to 45100 IU/ml (normal range less than 250). All AD patients had a positive RAST score to Der f and had a history of AD dating from infancy or childhood, associated allergenic rhinitis and/or asthma. Serum IgE levels were within the normal range and RAST scores to HDM were negative in patients with ED and normal individuals. None of the AD or ED patients had previously received systemic PBMC were isolated from heparinized venous blood by FicollPaque (Pharmacia LKB Biotechnology, Uppsala, Sweden) density gradient centrifugation. In some experiments, magnetic polystyrene beads coated with anti-CD4 and anti-CD8 mAbs (Dynabeads; Dynal, Oslo, Norway) were used to deplete PBMC of CD4 + and CD8 + cells, respectively, according to the manufacturer's instructions. The resulting samples contained less than 2% CD4 + or CD8 + cells as assessed by flow cytometry (FACScan; Becton Dickinson, Sunnyvale, Calif.) with the use of FITC-conjugated anti-Leu-3a or anti-Leu-2a mAb (Becton Dickinson). Cell viability was greater than 98% as determined by trypan blue dye exclusion.
Cells thus variously prepared (2 × 10 5 cells/well) were cultured in 96-well flat-bottomed microtitre plates (Corning Glass Works, Corning, N.Y.) in a final volume of 0.2 ml culture medium with 10 µg/ml Der f in a humidified atmosphere of air containing 5% CO 2 for 72 h at 37°C. Preliminary studies revealed that this concentration of stimulant was optimal for proliferation of PBMC. The effect of blocking of the B7/CD28 interaction on lymphocytic proliferation was examined by adding anti-CD80 or anti-CD86 mAb (5 µg/ml) at the start of culture.
To analyse frequency of Der f-reactive cells, PBMC (0.5 to 1 × 10 5 /well) were cultured in 96-well round-bottomed microtitre plates (Corning Glass Works) with or without 10 µg/ml Der f and assayed in replicates of 18 wells each for 72 h [26] . Cells incubated with 3% phytohaemagglutinin (PHA; Gibco) served as proliferation controls. Methyl 3 H-thymidine (Amersham, Arlington, Ill.) was added to cultures (1 µCi/well) 14 to 16 h before harvest. Cells were collected onto glass fibre filters using a cell harvester (Cambridge Technologies, Watertown, Mass.) and the uptake of radiation was measured using a scintillation counter. The results are expressed as mean counts per minute (cpm) of triplicates or as a stimulation index (SI) together with the standard error of the mean (SEM; routinely < 10%).
To examine the effect of neuropeptides, SP, SP(1-7) or SP(4-11) at 10 -8 , 10 -9 and 10 -10 M was added to the wells at the start of culture. Since the concentration of SP ranges from 0.25 to 1.6 pmol/g in biopsied skin of normal subjects and patients with various diseases such as AD, psoriasis and axillary hyperhidrosis [1, 11] , and is 5.58 ± 0.53 and 6.21 ± 0.61 pmol/l of plasma of normal subjects and psoriatic patients, respectively [6] , the concentrations used in the present study were thought to be physiological. SP was added at 10 -9 M together with spantide at the various concentrations.
Determination of the frequency of Der f-specific PBMC The response of PBMC to Der f in AD and normal subjects was determined by calculating the number of proliferating cells per 10 6 cells based on limiting dilution analysis and the Poisson distribution as previously described [30] .
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of cytokine mRNA expression PBMC (1 × 10 6 cells/well) were dispensed to 48-well culture plates (Corning Glass Works) with 1 ml of culture medium in the presence or absence of Der f in combination with 10 -9 M SP, and incubated in a humidified atmosphere of air containing 5% CO 2 for 6 h at 37°C. Total RNAs were prepared by guanidinium-thiocyanate lysis and acid phenol-chloroform extraction and analysed for IL-2, IL-4, IL-10, IFN-γ and β-actin mRNA as previously described [4] . Briefly, 2 µl of each RNA sample were reverse transcribed with a Takara RNA PCR kit (GeneAmp RNA PCR Kit; Takara Biomedicals, Osaka, Japan) according to the manufacturer's instructions. The resulting cDNA was subjected to 40 PCR cycles using a waterbath thermal cycler (Thermal Sequencer TSR-300; Iwaki Glass, Tokyo, Japan) as follows: cycle 1, 5 min at 94°C, 2 min at 55°C, and 3 min at 72°C; and cycles 2-40, 2 min at 94°C, 2 min at 55°C, and 3 min at 72°C [32] . All primer pairs spanned at least one intron in the respective genomic sequence, allowing discrimination between cDNA and genomic amplification products. The primers used were as follows. IL-2 5′ primer ATG-TACAGGATGCAACTCCTGTCTT, 3′ primer GTCAGTGTTG-AGATGATGCTTTGAC; IL-4 5′ primer ATGGGTCTCACCTC-CCAACTGCT, 3′ primer CGAACACTTTGAATATTTCTCTCT-CAT [17] ; IL-5 5′ primer GCTTCTGCATTTGAGTTTGCTA-GCT, 3′ primer TGGCCGTCAATGTATTTCTTTATTAAG [7] ; IL-10 5′ primer ATCAGCTGGACAACTTGTTG, 3′ primer GTC-CTAGAGTCTATAGAGTC [8] . IFN-γ 5′ primer ATGAAATAT-ACAAGTTATATCTTGGCTTT, 3′ primer GATGCTCTTCGAC-CTCGAAACAGCAT; β-actin 5′ primer TGACGGGGTCACCC-ACACTGTGCCCATCTA, 3′ primer CTAGAAGCATTGCGGT-GGACGATGGAGGG [17] .
PCR products were electrophoresed through 2% agarose. The gel was stained with ethidium bromide and the amplified DNA bands were visualized in an ultraviolet transilluminator. The presence of cytokine-specific mRNA transcripts was confirmed with the use of a DNA molecular weight marker VI (Boehringer Mannheim, Mannheim, Germany) electrophoresed in parallel. The photographed bands of RT-PCR products were scanned with a computerized scanner (JX-330M; SHARP, Osaka, Japan) and the density of the scanned band was quantified by image analysing software (NIH Image). The cytokine mRNA expression was semiquantified by calculating the relative density of cytokine PCR bands in relation to β-actin in the same sample.
Statistical method
The differences between the categories studied were analysed using the Student's t-test or Wilcoxon's signed-ranks test. Probability values less than 0.05 were considered significant.
Results
Proliferative responses of PBMC to Der f
Preliminary experiments using different concentrations of Der f to stimulate PBMC showed that 10 µg/ml of the allergen provided optimal responses in AD (data not shown). When PBMC from AD were stimulated with this concentration of Der f, the mean SI ± SD was 2.6 ± 1.3, significantly higher than in ED (1.2 ± 0.3) and normal subjects (0.9 ± 0.3) (Fig. 1) . The responsiveness of PBMC to HDM allergen was comparable between AD patients with negative RAST scores to Der f (n = 3) and normal subjects (data not shown). Since the magnitude of the proliferative response to Der f was variable among AD patients, if the SI exceeded the SI + 3SD of normal subjects, i.e. 1.8, individuals were considered to be highly responsive to Der f. Of 25 patients with AD, 16 had an SI greater than 1.8 and thus were considered high responders to Der f. The SI values of the high responders were not correlated with RAST scores to Der f (data not shown). Proliferative responses to PHA were comparable among AD and ED patients and normal subjects. These results indicate that proliferation to Der f in the high responders was specific and not because of the presence of dermatitis.
Removal of CD4 + cells, but not CD8 + cells, from PBMC abrogated the proliferative responses (Table 1) . Blocking of the B7/CD28 interaction with anti-CD80 or anti-CD86 mAb showed that the responses were dependent on CD80 and CD86. The addition of isotypematched control immunoglobulin did not abrogate the proliferative responses. Therefore, responses to Der f were mediated by CD4 + T cells via costimulatory signals delivered to CD28 through B7 molecules on antigen-presenting cells.
The frequency of Der f-reactive cells in PBMC
The frequency of Der f-reactive T cells was significantly higher in patients with AD than in normal individuals (Fig. 2) . The means ± SD were 24.32 ± 27.29/10 6 cells in AD patients (n = 9) and 1.74 ± 2.73/10 6 cells in normal subjects (n = 9), when calculated based on a frequency of 0.284/10 6 cells as the lowest that can be theoretically detectable by the present method. Seven out of nine AD patients had frequencies above the detectable level and were found to be high responders. In two patients with an undetectable frequency and the normal subjects, the SI was less than 1. 72 h. The percentage changes in proliferation resulting from the addition of SP at 10 -10 , 10 -9 and 10 -8 M were analysed using Wilcoxon's signed ranks test. As shown in Fig. 3 , although there was a marked interindividual variability in the percentage change, SP significantly enhanced Der f-induced proliferative responses at these concentrations. It has been demonstrated that the substitute peptide of SP, SP(4-11), stimulates human T cell proliferation in vitro in response to mitogen at concentrations as low as 10 -10 M [23] . Furthermore, enhancement of lymphocytic proliferation in response to SP is abrogated in the presence of the SP antagonist, spantide. Therefore, we examined the effect of these reagents on the proliferative responses to Der f of PBMC from the responder patients and analysed the results by Student's t-test. The enhancing effect was comparable between SP and SP(4-11) at 10 -9 M but was not apparent with SP(1-7) at the same concentration (Fig. 4A) , indicating that the C-, but not the N-terminal portion of SP was responsible for the observed effect.
The capacity of spantide to antagonize the effect of SP on Der f-induced proliferation was examined by adding both peptides simultaneously to cultures. The concentration of SP was fixed at 10 -9 M and the concentrations of spantide were varied from 10 -10 to 10 -8 M. Spantide alone neither enhanced nor suppressed lymphocytic proliferation induced by Der f (Fig. 4B) . However, the enhancing effect of SP on Der f-induced responses was abrogated with spantide at 10 -9 and 10 -8 M, but not at 10 -10 M. The (1-7), SP(4-11) and spantide on lymphocytic proliferation in response to to Der f in PBMC from AD patients. PBMC from responder patients were cultured with 10 µg/ml Der f in the presence of SP, SP(1-7) or SP(4-11) at 10 -9 M (A), or in the presence of SP at 10 -9 M plus spantide at the indicated concentrations (B). Each bar represents the mean SI ± SEM of triplicate determinations in PBMC from five individuals (* P < 0.05, NS not significant) proliferation of PBMC without Der f was not influenced by the SP substitutes at the concentrations tested. Therefore, the enhancing effect of SP on the response to Der f was mediated by specific binding of SP to its receptors.
Effects of SP on cytokine mRNA expression by atopic PBMC stimulated with Der f
It has been shown that allergen-specific T cell lines and clones produce Th2 type cytokines upon specific stimulation [14, 25, 27] . However, quantification of cytokines produced by PBMC consisting of heterogeneous cell populations seems to be difficult at the protein level because only a small proportion of cells responds specifically to a particular stimulant. Therefore, we examined cytokine production at the transcriptional level. PBMC from the responder patients were stimulated with 10 µg/ml Der f or unstimulated, and the mRNA extracted at 6 h was evaluated by RT-PCR. Whereas mRNA transcripts for IL-2, IFN-γ, IL-4 and IL-10 were detected in the absence of the stimulant, the expression of mRNA for IL-2 was slightly but significantly enhanced after Der f stimulation (Fig.  5A, C) . The IL-5 message was virtually undetectable in unstimulated cells but was induced by Der f stimulation. There was virtually no effect of Der f on the expression of mRNA for IFN-γ, IL-4 or IL-10. Changes in the cytokine profile were not observed in CD4 + cell-depleted populations (data not shown).
When SP at 10 -9 M was added to cultures stimulated with Der f, the intensity of IL-5 mRNA expression was reduced and IL-10 mRNA expression was enhanced (Fig.  5B) . On the other hand, the expression of mRNA for IL-2, IFN-γ and IL-4 was not influenced by SP irrespective of the effects of Der f on mRNA expression. SP alone did not alter mRNA expression. The addition of spantide together with SP to Der f cultures at the same concentration abrogated the effect of SP on cytokine mRNA expression (data not shown). In low responder AD patients (SI < 1.8), the expression of mRNA for these cytokines was not influenced by Der f or SP alone.
Discussion
The present study showed that PBMC from AD patients with positive RAST scores for Der f proliferated in vitro upon stimulation with Der f allergen in a B7-dependent manner and strongly expressed IL-2 and IL-5 mRNA but showed no changes in the levels of expression of mRNA for IL-4, IL-10 or IFN-γ, and that SP at physiological concentrations enhanced the proliferation in association with upregulation of IL-10 mRNA expression and downregulation of IL-5 mRNA expression. Since SP is released from peripheral nerve endings in the skin, these results suggest an immunoregulatory effect of this neuropeptide on cutaneous allergic inflammation that might occur in response to HDM allergens in AD.
Because the SIs of individual AD patients varied from 0.7 to 5.6, reflecting low frequencies of Der f-reactive lymphocytes, we tentatively defined those with an SI greater than 1.8 as high responders on the basis of the SI values of normal subjects. In high responders who comprised about two-thirds of the AD patients, the frequencies of Der f-reactive PBMC as determined by limiting dilution and proliferation assays were significantly higher than in low responders (with SI < 1.8) and normal subjects. Previous studies have shown that HDM-specific Th2 cells are more frequent in the skin of AD patients, constituting 1% to 3% of lesional T cells, than in the blood by an or- [27] , indicating preferential accumulation of this cell type.
Upon stimulation with Der f the expression of mRNA for both Th1 cytokine (IL-2) and Th2 cytokine (IL-5) was upregulated or induced in AD PBMC. The expression of IL-4, IL-10 and IFN-γ mRNA was unchanged. These results indicate that the recognition of HDM allergens by atopic T cells in association with the CD28/B7 pathway might be affected by an increase in the production of IL-2 brought about by the accumulation and stabilization of IL-2 mRNA and the direct upregulation of the IL-2 enhancer [15] . Although produced by Th0 and/or Th1 cells, IL-2 acts on Th2 cells as well and thus serves as a growth factor and cytokine producer for both Th1 and Th2 cells [18] . Stimulation of peripheral blood cells with Der f also resulted in preferential induction of IL-5 mRNA. Since Th2 cells are the main source of IL-5 among PBMC, it has been suggested that the mRNA is expressed in this cell type. Similar observations have been made at HDM patch test sites in AD patients [33] . These results strengthen the notion that not only Th2-but also Th1-like responses occur in vivo in allergen-induced inflammation in AD [12, 31] .
In accordance with the enhancement of mitogen-and antigen-induced lymphocyte proliferation by SP [20, 22] , physiological concentrations of SP and its C-terminal fragment, SP(4-11), enhanced the proliferation in response to Der f by up to 60-70% via binding to specific receptors. In normal individuals, while various cell types in the peripheral blood express SP receptors, only a small proportion of each cell type expresses SP receptors and the number of SP receptors per cell varies widely [24] . These observations may explain the interindividual variability in the effect of SP on lymphocytic responses in the present study. Despite such variability the enhancement of cell proliferation by SP was always associated with upregulated expression of IL-10 mRNA and downregulation of IL-5 mRNA expression.
It has been reported that SP enhances IL-2 mRNA expression and IL-2 secretion following mitogenic and antigenic stimulation in T cell clones and peripheral blood T cells [3] , suggesting preferential activation of Th0/Th1 cells. The RT-PCR method in the present study did not detect such an enhancement probably owing to the small numbers of T cells bearing SP receptors that produced IL-2 following Der f stimulation. Upregulation of IL-10 mRNA expression was noted only after Der f stimulation in association with SP; neither stimulant alone exerted such an effect. IL-10 is produced by various human cells including Th1 and Th2 cells, B cells and monocytes [5] . Thus, it is possible that not only subsets of Der f-reactive T cells but also non-T cells such as B cells proliferated and secreted IL-10 in the presence of the allergen and SP. Downregulation of IL-5 mRNA expression is in accordance with the inhibition by IL-10 of CD 28/B7-dependent production of IL-5 by human T cells [28] . Alternatively SP might be suppressive in subsets of Th2 cells that produce IL-5.
In addition, the possibility that the effect of SP was mediated indirectly by antigen-presenting cells should be considered. For example, SP regulates monocyte functions such as the induction of the release of IL-1, IL-6 and TNF-α, and the activation of arachidonic acid metabolism, chemotaxis and the oxidative burst [16, 29] . Therefore, the alteration of Der f-induced cytokine responses by SP stimulation despite promotion of proliferation suggests that the neuropeptide influences cutaneous inflammation caused by HDM allergens in AD through modifying the cytokine patterns in infiltrating cells.
The significance of the present in vitro studies is supported by the antidromic release of SP from peripheral nerve terminals into surrounding tissues and changes in both SP levels and the number of SP-containing nerves in eczematous lesions of AD patients [2, 9] . In psoriasis in which the initiation and exacerbation result from stressful events, Farber et al. [10] have proposed a novel sensory pathway for transmitting emotional responses to stress to the periphery, resulting in the antidromic release of neuropeptides in the skin. Although it remains unknown whether the same or a similar mechanism is operative in AD [19] , neuropeptides with potent immunoregulatory functions such as SP released locally in response to mental or physical stress may influence cutaneous inflammation by acting on various immune cell types thus worsening or improving the clinical manifestations of AD.
